Ligand validation:5EYU

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5EYU_EPE_B_504	25%	28%	0.18	0.816	1.94	1.12	1	2	0	0	100%	0.5
5EYU_EPE_A_504	16%	21%	0.21	0.774	2.17	1.35	1	2	0	0	100%	0.5
5EYU_EPE_B_505	7%	27%	0.214	0.662	2.01	1.09	1	2	0	0	100%	0.8
5EYU_EPE_C_504	5%	25%	0.266	0.667	1.93	1.3	1	2	0	0	100%	1
5EZ4_EPE_A_504	78%	22%	0.103	0.945	1.64	1.76	1	3	1	0	100%	1
5DIB_EPE_A_503	46%	25%	0.141	0.877	2.01	1.21	1	1	0	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	45%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	18%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	29%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	45%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.